Medtronic plc (MDT) Earnings History
Steady Earner37 years of earnings data (1990–2026) · Positive but moderate multi-year EPS trajectory
Loading earnings history...
Medtronic plc (MDT) Earnings Overview
As of July 7, 2026, Medtronic plc (MDT) reported trailing twelve-month net income of $4.80B, reflecting +3.3% year-over-year growth. The company earned $3.73 per diluted share over the past four quarters, with a net profit margin of 13.2%.
Looking at the long-term picture, MDT's 5-year EPS compound annual growth rate (CAGR) stands at +7.0%, showing solid earnings momentum. The company achieved its highest annual net income of $5.04B in fiscal 2022.
Medtronic plc maintains positive profitability with a gross margin of 65.0%, operating margin of 17.8%, and net margin of 13.2%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including ABT ($6.28B net income, 14.7% margin), BSX ($3.55B net income, 14.4% margin), EW ($1.09B net income, 17.7% margin), MDT has room to improve margins relative to the peer group. Compare MDT vs ABT →
MDT Earnings vs Peers
Earnings metrics vs comparable public companies
MDT Historical Earnings Data (1990–2026)
37 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2026 | $4.80B | +3.0% | $6.47B | $3.73 | 13.2% | 17.8% |
| 2025 | $4.66B | +26.8% | $5.96B | $3.61 | 13.9% | 17.8% |
| 2024 | $3.68B | -2.2% | $5.14B | $2.76 | 11.4% | 15.9% |
| 2023 | $3.76B | -25.4% | $5.49B | $2.82 | 12.0% | 17.6% |
| 2022 | $5.04B | +39.7% | $5.75B | $3.73 | 15.9% | 18.2% |
| 2021 | $3.61B | -24.7% | $4.48B | $2.66 | 12.0% | 14.9% |
| 2020 | $4.79B | +3.4% | $4.79B | $3.54 | 16.6% | 16.6% |
| 2019 | $4.63B | +49.2% | $6.27B | $3.41 | 15.2% | 20.5% |
| 2018 | $3.10B | -22.9% | $6.64B | $2.27 | 10.4% | 22.2% |
| 2017 | $4.03B | +13.8% | $5.38B | $2.89 | 13.6% | 18.1% |
| 2016 | $3.54B | +32.3% | $5.36B | $2.48 | 12.3% | 18.6% |
| 2015 | $2.67B | -12.7% | $3.77B | $2.41 | 13.2% | 18.6% |
| 2014 | $3.06B | -11.6% | $3.81B | $3.02 | 18.0% | 22.4% |
| 2013 | $3.47B | -4.1% | $4.40B | $3.37 | 20.9% | 26.5% |
| 2012 | $3.62B | +16.8% | $4.48B | $3.41 | 22.3% | 27.7% |
| 2011 | $3.10B | -0.1% | $4.46B | $2.86 | 19.4% | 28.0% |
| 2010 | $3.10B | +42.9% | $4.79B | $2.79 | 19.6% | 30.3% |
| 2009 | $2.17B | -2.8% | $3.46B | $1.84 | 14.9% | 23.7% |
| 2008 | $2.23B | -20.4% | $3.65B | $1.95 | 16.5% | 27.0% |
| 2007 | $2.80B | +10.0% | $3.74B | $2.41 | 22.8% | 30.4% |
| 2006 | $2.55B | +41.2% | $3.71B | $2.09 | 22.6% | 32.8% |
| 2005 | $1.80B | -7.9% | $3.44B | $1.48 | 17.9% | 34.3% |
| 2004 | $1.96B | +22.5% | $3.18B | $1.60 | 21.6% | 35.0% |
| 2003 | $1.60B | +62.6% | $2.65B | $1.30 | 20.9% | 34.6% |
| 2002 | $984M | -5.9% | $2.15B | $0.80 | 15.3% | 33.5% |
| 2001 | $1.05B | -4.8% | $1.88B | $0.85 | 18.8% | 33.8% |
| 2000 | $1.10B | +134.5% | $1.68B | $0.89 | 21.9% | 33.6% |
| 1999 | $468M | -21.2% | $1.36B | $0.39 | 11.3% | 32.9% |
| 1998 | $595M | +2.0% | $1.09B | $0.51 | 22.8% | 41.9% |
| 1997 | $583M | +36.2% | $914M | $0.50 | 23.9% | 37.5% |
| 1996 | $428M | +45.7% | $636M | $0.45 | 19.7% | 29.3% |
| 1995 | $294M | +26.5% | $436M | $0.32 | 16.9% | 25.0% |
| 1994 | $232M | +17.8% | $333M | $0.25 | 16.7% | 23.9% |
| 1993 | $197M | +22.1% | $295M | $0.21 | 14.8% | 22.2% |
| 1992 | $162M | +21.1% | $246M | $0.17 | 13.7% | 20.9% |
| 1991 | $133M | +22.7% | $206M | $0.14 | 13.1% | 20.2% |
| 1990 | $109M | - | $165M | $0.12 | 13.0% | 19.7% |
Download Data
Export MDT earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
36+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
MDT — Frequently Asked Questions
Quick answers to the most common questions about buying MDT stock.
What is MDT earnings per share (EPS)?
MDT trailing twelve-month (TTM) diluted EPS is $3.73, reflecting +3.3% year-over-year growth. The 5-year EPS CAGR is +7.0%. Complete EPS history from 1990 to 2026 is available in the table on this page.
What is Medtronic plc's net income?
Medtronic plc (MDT) trailing twelve-month net income is $4.8B as of 2026. Earnings grew +3.3% year-over-year. Medtronic plc has been profitable for 37 consecutive years.
Is MDT profitable?
Yes, MDT is profitable with a TTM net income of $4.8B and a net profit margin of +13.2%. Medtronic plc has generated profits for 37 consecutive years.
What is MDT's earnings growth rate?
MDT compound annual EPS growth rates (CAGR): 1-Year: +3.3%, 3-Year: +9.8%, 5-Year: +7.0%, 10-Year: +4.2%. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1990 to 2026.
What are MDT's profit margins?
Medtronic plc net profit margin is +13.2%, operating margin is +17.8%, and gross margin is +65.0%. Margins are within a typical range for the sector. Return on Equity is +9.8%.
Is MDT growing earnings?
MDT earnings growth is slowing. Current YoY EPS growth of +3.3% trails the 5-year CAGR of +7.0%. TTM net income is $4.8B.
What was MDT's best earnings year?
Medtronic plc's highest annual net income on record is $5.0B, achieved in fiscal year 2022. Earnings history on this page spans 1990 to 2026 and includes all annual and quarterly figures.
What were MDT's earnings last quarter?
MDT's most recent reported quarter was Q4 2026. Net income was $1.2B with diluted EPS of $0.96. For a full breakdown of all quarters, see the quarterly earnings table on this page.